Arlene H. Sharpe
Affiliations: | Harvard University, Cambridge, MA, United States |
Area:
Cell Biology, Microbiology BiologyGoogle:
"Arlene Sharpe"Children
Sign in to add trainee| Tammy T. Chang | grad student | 2003 | Harvard |
| Spencer C. Liang | grad student | 2005 | Harvard |
| Keturah E. Brown | grad student | 2010 | Harvard |
| Peter T. Sage | grad student | 2013 | Harvard |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Burke KP, Chaudhri A, Freeman GJ, et al. (2024) The B7:CD28 family and friends: Unraveling coinhibitory interactions. Immunity. 57: 223-244 |
| Cohen JN, Gouirand V, Macon CE, et al. (2024) Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche. Science Immunology. 9: eadh0152 |
| Denize T, Jegede OA, Matar S, et al. (2023) PD-1 Expression on Intratumoral Regulatory T Cells is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear Cell Renal Cell Carcinoma Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Georgiev P, Benamar M, Han S, et al. (2023) Regulatory T cells in dominant immunologic tolerance. The Journal of Allergy and Clinical Immunology |
| Rowe JH, Elia I, Shahid O, et al. (2023) Formate supplementation enhances anti-tumor CD8+ T cell fitness and efficacy of PD-1 blockade. Cancer Discovery |
| Kurmi K, Liang D, van de Ven R, et al. (2023) Metabolic modulation of mitochondrial mass during CD4 T cell activation. Cell Chemical Biology |
| Collier JL, Pauken KE, Lee CAA, et al. (2023) Single-cell profiling reveals unique features of diabetogenic T cells in anti-PD-1-induced type 1 diabetes mice. The Journal of Experimental Medicine. 220 |
| Bod L, Kye YC, Shi J, et al. (2023) B-cell-specific checkpoint molecules that regulate anti-tumour immunity. Nature |
| Burke KP, Markson SC, Sharpe AH. (2023) Tracking tumor-specific CD8 T cell responses. Trends in Immunology |
| Datta M, Chatterjee S, Perez EM, et al. (2023) Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models. Proceedings of the National Academy of Sciences of the United States of America. 120: e2219199120 |